Centiva Capital’s Carlsmed CARL Stock Holding History

Centiva Capital’s Portfolio CARL Stock Details CARL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$155K	Buy	14,891 +2,146	+17%	+$22.6K	﹤0.01%	1469
2026 Q1	$115K	Buy	+12,745	New	+$154K	﹤0.01%	1363

Other funds holding CARL

Jupiter Topco New York $245B AUM

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM Capital Shawnee, Kansas $618M AUM

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Centiva Capital's CARL Position: Q2 2026 in Review

Centiva Capital increased its Carlsmed (CARL) stake by 17% in Q2 2026, buying an estimated $22.6K and bringing the position to 14,891 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

Centiva Capital first reported a position in CARL in Q1 2026 and has held it in 2 quarters since. 75 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

Centiva Capital held 14,891 shares of Carlsmed worth $155K as of Q2 2026.
Centiva Capital bought 2,146 Carlsmed shares in Q2 2026, an estimated $22.6K.
Carlsmed made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1469 holding.
Centiva Capital first reported a position in Carlsmed in Q1 2026 and has held it in 2 quarters since.
75 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.